Most Recent
Merck Sharp & Dohme settles trade mark spat with German drug company
Intellectual Property 2020-10-05 12:45 pm By Cat Fredenburgh

US drug company Merck Sharp & Dohme has settled trade mark litigation brought by German drug maker Merck KGaA alleging it violated a 1970 agreement by using the “Merck” mark in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Nthalmic directors accused of misusing confidential information in lens patent applications
Intellectual Property 2020-09-15 6:10 pm By Miklos Bolza

Sydney-based research foundation Brien Holden Vision Institute has filed a lawsuit alleging three senior researchers misused confidential information when they jumped ship to a rival research group and filed applications to patent seven inventions for opthalmic lenses designed to treat myopia allegedly based on that information.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ex-Piper Alderman partner’s evidence of sex discrimination falls short, judge says
Employment 2020-09-09 7:21 pm By Christine Caulfield

Evidence of an outdated management approach and bullying — which included threatening defamation proceedings against two junior lawyers that complained about her — appear to be responsible for the ousting of a former senior Piper Alderman partner, not her sex, a judge has found.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ousted Piper Alderman partner can’t bring sex discrimination claims against firm
Employment 2020-09-07 5:44 pm By Miklos Bolza

A former Piper Alderman partner has lost her bid to bring sex discrimination claims against the partners of the law firm, but can still proceed with her other claims.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sizzler seeks quick win in bun fight with Burger Urge  
Intellectual Property 2020-08-21 2:39 pm By Alison Eveleigh

Buffet restaurant pioneer Sizzler is seeking a quick win in its trade mark stoush with Brisbane-based Burger Urge tossed, telling a court it will be seeking summary judgment in its favour.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sandoz wins appeal of $26.3M infringement ruling in IP battle over Lexapro
Intellectual Property 2020-08-04 3:05 pm By Miklos Bolza

Generic drug maker Sandoz has successfully appealed a $26.3 million judgment finding it infringed a patent owned by rival H Lundbeck relating to the top-selling antidepressant Lexapro.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Tile maker Ceramiche wins trade mark fight with Caesarstone after ‘honest use’ ruling
Intellectual Property 2020-07-29 3:28 pm By Christine Caulfield

Tile maker Ceramiche Caesar has prevailed in its challenge to a judge’s ruling allowing building products manufacturer Caesarstone to register two trade marks despite a finding that they were deceptively similar to one of its marks.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Coffee capsule maker Caffitaly appeals ruling invalidating three patents
Intellectual Property 2020-07-20 1:56 pm By Christine Caulfield

Coffee capsule maker Caffitaly is challenging a ruling that revoked three patents at the centre of an intellectual property war with rival One Collective.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Mylan loses Lipidil appeal, despite court finding proof of intention not needed for Swiss-style claims
Intellectual Property 2020-07-03 5:27 pm By Miklos Bolza

Mylan Health has lost its challenge to a ruling that invalidated three patents related to its blockbuster cholesterol drug Lipidil, despite the appeals court finding the primary judge had erred by ruling that proof of intention was required for Swiss-style claims.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Janssen to expand patent case against Juno over generic HIV drug
Intellectual Property 2020-07-01 4:40 pm By Miklos Bolza

Drug manufacturer Janssen wants to expand its high stakes case against Juno Pharmaceuticals over its HIV drug Prezista, alleging Juno’s plans to launch a generic version of the drug threaten another one of its patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?